Chong Kun Dang Launches Six Types of "Modcol Strong" and "Modcol Ibu" Cold Soft Capsules
Broader Range of Ingredient-Based Choices Tailored to Symptoms
On August 31, Chong Kun Dang announced the launch of three types of "Modcol Strong Soft Capsules," a cold medicine, and three types of "Modcol Ibu Soft Capsules."
With this new product release, the Modcol soft capsule lineup has expanded to include both acetaminophen-based Modcol Strong and ibuprofen-based Modcol Ibu products.
The Modcol Strong Soft Capsule series consists of three types: Cold, Nose, and Cough, tailored to different cold symptoms. In accordance with the revised pharmaceutical standard manufacturing criteria implemented last year, each capsule contains 250 mg of acetaminophen, raising the total daily dosage to the maximum limit of 1,500 mg. Among these, the Cold and Cough types also include bromhexine hydrochloride, an expectorant ingredient.
The Modcol Ibu Soft Capsule series is also available in three variants: Cold, Nose, and Cough. Each of these products contains 75 mg of ibuprofen per capsule, which is designed to alleviate fever and pain, and suppress inflammatory responses. The total daily dose amounts to 450 mg, which meets the maximum allowed by standard manufacturing criteria.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A Chong Kun Dang representative stated, "This new product line features more segmented offerings based on acetaminophen and ibuprofen, giving cold sufferers a wider range of options tailored to their symptoms and the unique properties of each ingredient." The representative added, "We will continue to launch over-the-counter drugs that reflect varying consumer needs in the future."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.